Charlotte B.
- Country
- France
- Department
- Medical Oncology
Research Overview
- Study of Inavolisib with Trastuzumab and Pertuzumab as Maintenance Therapy in Patients with HER2‑Positive PIK3CA‑Mutated Locally Advanced or Metastatic Breast Cancer
- Efficacy and Safety of Lasofoxifene and Abemaciclib vs. Fulvestrant and Abemaciclib in ER+/HER2- Advanced Breast Cancer with ESR1 Mutation
- Phase III Randomized Trial of Platinum-Based Chemotherapy with Paclitaxel, Bevacizumab, and Atezolizumab in Metastatic, Persistent, or Recurrent Cervical Carcinoma
Data & Insights
Has run more than one trial at 192 of 405 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in treating various forms of breast cancer, with particular focus on hormone receptor-positive (ER+) and HER2-negative breast cancer. Their expertise extends to both early-stage and advanced disease management.
- Early-stage breast cancer treatment optimization
- Advanced metastatic breast cancer management
- Triple-negative breast cancer therapeutics
The research encompasses novel therapeutic approaches for patients with ESR1 mutations and exploration of extended endocrine therapy strategies.
Gynecologic Oncology
The investigator demonstrates significant involvement in treating advanced gynecologic malignancies, particularly focusing on ovarian cancer and cervical cancer therapeutic innovations.
- Advanced ovarian cancer treatment
- Fallopian tube and peritoneal cancer therapy
- Cervical cancer management strategies
Their work includes investigation of combination therapies for platinum-resistant cases and novel approaches in metastatic cervical cancer treatment.
Therapeutic Innovation
The investigator explores innovative combination treatment approaches incorporating targeted therapies and immunotherapy across various gynecologic and breast cancers.
- Novel drug combinations
- Endocrine therapy advancement
- Immunotherapy integration
Research focuses on developing more effective treatment strategies for hormone-dependent cancers and resistant disease states.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.